Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPB-1734 in advanced solid tumors
NCT04643418Phase 2Recruiting
- Sponsor
- MegaPro Biomedical
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MPB-1734 in solid tumor, sponsored by MegaPro Biomedical. Started Mar 2022; status: recruiting.
02
Drugs
MPB-1734
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04643418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643418.